Quoin Registers Resale of 9.37M ADSs from $30.8M Private Placement
QNRX has more than doubled off its 52-week low of $3.25.
Summary
Quoin filed an S-3 to register resale of 9.37M ADSs from its August private placement, making them tradable and creating potential dilution of up to 144% of current shares outstanding.
Updates
· SEC 424B3 — The 424B3 prospectus registers the same 9,371,895 ADSs for resale, with ADSs outstanding prior to the offering at 4,804,161 and up to 11,730,256 after full exercise of warrants.
Key Events · Financing and Capital Events · QNRX
-
Resale Registration of 9.37M ADSs
S-3 registers 9,371,895 ADSs for resale by selling shareholders from the August 2026 private placement — 2,445,800 Offered ADSs, 3,802,130 Pre-Funded ADSs, and 3,123,965 Ordinary Warrant ADSs.
-
Potential Dilution of 144.2%
The ADSs covered by this prospectus and not currently outstanding represent approximately 144.2% of the 4,804,161 ADSs outstanding as of September 16, 2026, creating substantial potential dilution for existing shareholders.
-
Up to $19.1M from Warrant Exercises
Company could receive up to approximately $19.1 million, less placement agent fees, if all Ordinary Warrants (exercise price $6.10 per ADS) are exercised for cash.
-
Shareholder Vote on Ownership Cap
Purchase Agreement requires a shareholder meeting within 90 days of closing to seek approval to increase beneficial ownership limitation from 4.99% to 9.99% for Purchasers and October 2025 investors.
Analysis · QNRX · Life Sciences
This S-3 registers for resale 9,371,895 ADSs issued in the August 2026 private placement, representing approximately 144.2% of the 4,804,161 ADSs currently outstanding. The registration makes these shares tradable, creating significant potential overhang on the stock. The company could receive up to $19.1 million if all Ordinary Warrants (exercise price $6.10/ADS) are exercised for cash, extending its runway. A shareholder vote within 90 days will seek to raise the beneficial ownership cap from 4.99% to 9.99%, which could concentrate voting power among existing institutional holders.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 29.4% of the 1560 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, QNRX was trading at $7.06 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14.1M. The 52-week trading range was $3.25 to $41.80. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.